During the last session, Prothena Corporation plc (NASDAQ:PRTA)’s traded shares were 1.71 million, with the beta value of the company hitting 0.12. At the end of the trading day, the stock’s price was $7.10, reflecting an intraday loss of -2.61% or -$0.19. The 52-week high for the PRTA share is $25.42, that puts it down -258.03 from that peak though still a striking -0.99% loss since the share price plummeted to a 52-week low of $7.17. The company’s market capitalization is $382.17M, and the average trade volume was 739.74K shares over the past three months.
Prothena Corporation plc (PRTA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.40. PRTA has a Sell rating from 1 analyst(s) out of 15 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 11 recommend a Buy rating for it.
Prothena Corporation plc (NASDAQ:PRTA) trade information
Prothena Corporation plc (PRTA) registered a -2.61% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.61% in intraday trading to $7.10, hitting a weekly high. The stock’s 5-day price performance is -18.58%, and it has moved by -32.25% in 30 days. Based on these gigs, the overall price performance for the year is -70.09%.
The consensus price target of analysts on Wall Street is $56, which implies an increase of 87.32% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $24 and $98 respectively. As a result, PRTA is trading at a discount of -1280.28% off the target high and -238.03% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -3.15%. While earnings are projected to return -54.33% in 2025, the next five years will return -15.39% per annum.
PRTA Dividends
Prothena Corporation plc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 8.07 million shares, is of FMR LLC’s that is approximately 15.0012% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $166.48 million.
Also, the Mutual Funds coming in first place with the largest holdings of Prothena Corporation plc (PRTA) shares are VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund . Data provided on Jan 31, 2025 indicates that VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund owns about 4.22 shares. This amounts to just over 7.84 percent of the company’s overall shares, with a $29.96 million market value. The same data shows that the other fund manager holds slightly less at 2.32, or about 4.31% of the stock, which is worth about $16.46 million.
